The FDA has granted 510(k) clearance to Medtronic’s (NYSE:MDT) Stealth Autoguide, a cranial robotic guidance system used for spatial positioning and orientation of instrument holders or tool guides during neurosurgical procedures. The device is part of the company’s Surgical Synergy platform.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.